Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.
Brody JD, Jørgensen JM Dr, Belada D, Costello R, Trněný M, Vitolo U, Lewis DJ, Karimi YH, Sureda A, Andre M, Wahlin BE, Lugtenburg PJ, Jiang T, Karagoz K, Steele AJ, Abbas A, Wang L, Risum M, Cordoba R.
Brody JD, et al. Among authors: wang l.
Blood. 2025 Jan 10:blood.2024026830. doi: 10.1182/blood.2024026830. Online ahead of print.
Blood. 2025.
PMID: 39792928